On March 30-31, 2025, global stock markets experienced a significant downturn, with Japan's Nikkei entering correction territory after a 4% slump. This decline was largely attributed to concerns over potential tariffs initiated by former President Trump, impacting Asian and European markets.

On March 30, 2025, the TA 35 index in Israel closed lower, registering a decrease of 1.37%, reflecting a negative sentiment in the Israeli stock market.

On March 31, 2025, EQT and First Kraft made a joint offer to acquire Fortnox, valuing the company at $5.5 billion, signaling a significant potential acquisition in the market.

On March 31, 2025, Aston Martin announced plans to raise $161.8 million from investments, anticipating the impact of potential U.S. tariffs on its business operations.

On March 31, 2025, Reach PLC announced that CEO Jim Mullen is stepping down from his position, with Piers North taking over as the new CEO, a change that could influence the company's stock performance.

On March 31, 2025, Keller Group announced the initiation of a multiyear share-buyback program with a total value of $32.4 million, reflecting confidence in the company's financial position.

On March 30, 2025, reports indicated that Domain Holdings in Australia is expected to recommend CoStar's $1.8 billion buyout bid, suggesting a positive outlook for the acquisition.

On March 31, 2025, Toyota announced its strategy to maintain current operations and costs in response to potential U.S. tariffs, aiming to minimize the impact on its business.

On March 31, 2025, an analysis by Reuters suggested that a shrinking risk premium in the U.S. could lead to a diversion of investment cash flow into European markets, potentially boosting European economies.

On March 31, 2025, BMO Capital issued a stock market update, upgrading Steel Dynamics while downgrading United States Steel, indicating a shift in their outlook for these companies.

On March 31, 2025, HSBC reaffirmed its positive stance on bank stocks, despite the prevailing economic uncertainty, indicating confidence in the banking sector's resilience.

On March 31, 2025, biotech stocks experienced a downturn following the announcement of the FDA's top vaccine regulator's impending departure, raising concerns about future vaccine approvals and regulatory stability.